|
57
|
154
|
3av9A |
Crystal structures of novel allosteric peptide inhibitors of hiv integrase in the ledgf binding site |
|
3
|
21
|
3abeZ |
Structure of human rev7 in complex with a human rev3 fragment in a tetragonal crystal |
|
76
|
269
|
3ai4A |
Crystal structure of yeast enhanced green fluorescent protein - mouse polymerase iota ubiquitin binding motif fusion protein |
|
51
|
153
|
3ao2A |
Fragment-based approach to the design of ligands targeting a novel site on hiv-1 integrase |
|
2
|
21
|
3abdX |
Structure of human rev7 in complex with a human rev3 fragment in a monoclinic crystal |
|
218
|
773
|
3a2fA |
Crystal structure of pyrococcus furiosus dna polymerase/pcna monomer mutant complex |
|
16
|
99
|
3aidA |
A new class of hiv-1 protease inhibitor: the crystallographic structure, inhibition and chemical synthesis of an aminimide peptide isostere |
|
2
|
13
|
2zvmU |
Crystal structure of pcna in complex with dna polymerase iota fragment |
|
1
|
20
|
2zvkU |
Crystal structure of pcna in complex with dna polymerase eta fragment |
|
16
|
99
|
2zyeA |
Structure of hiv-1 protease in complex with potent inhibitor kni-272 determined by neutron crystallography |
|
0
|
11
|
2zvlU |
Crystal structure of pcna in complex with dna polymerase kappa fragment |
|
17
|
99
|
3a2oA |
Crystal structure of hiv-1 protease complexed with kni-1689 |
|
18
|
99
|
2z4oA |
Wild type hiv-1 protease with potent antiviral inhibitor grl-98065 |
|
121
|
424
|
2zd1B |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with tmc278 (rilpivirine), a non-nucleoside rt inhibitor |
|
20
|
99
|
2z54A |
The influence of i47a mutation on reduced susceptibility to the protease inhibitor lopinavir |
|
20
|
99
|
2zgaA |
Hiv-1 protease in complex with a dimethylallyl decorated pyrrolidine based inhibitor (hexagonal space group) |
|
136
|
552
|
2ze2A |
Crystal structure of l100i/k103n mutant hiv-1 reverse transcriptase (rt) in complex with tmc278 (rilpivirine), a non-nucleoside rt inhibitor |
|
104
|
428
|
2ze2B |
Crystal structure of l100i/k103n mutant hiv-1 reverse transcriptase (rt) in complex with tmc278 (rilpivirine), a non-nucleoside rt inhibitor |
|
159
|
554
|
2zd1A |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with tmc278 (rilpivirine), a non-nucleoside rt inhibitor |
|
113
|
424
|
2yniB |
Hiv-1 reverse transcriptase in complex with inhibitor gsk952 |
|
114
|
424
|
2yngB |
Hiv-1 reverse transcriptase in complex with inhibitor gsk560 |
|
163
|
557
|
2yknA |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with a difluoromethylbenzoxazole (dfmb) pyrimidine thioether derivative, a non-nucleoside rt inhibitor (nnrti) |
|
168
|
560
|
2yngA |
Hiv-1 reverse transcriptase in complex with inhibitor gsk560 |
|
113
|
424
|
2ynhB |
Hiv-1 reverse transcriptase in complex with inhibitor gsk500 |
|
103
|
427
|
2ykmB |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with a difluoromethylbenzoxazole (dfmb) pyrimidine thioether derivative, a non-nucleoside rt inhibitor (nnrti) |
|
156
|
557
|
2ykmA |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with a difluoromethylbenzoxazole (dfmb) pyrimidine thioether derivative, a non-nucleoside rt inhibitor (nnrti) |
|
164
|
560
|
2ynhA |
Hiv-1 reverse transcriptase in complex with inhibitor gsk500 |
|
111
|
423
|
2ynfB |
Hiv-1 reverse transcriptase y188l mutant in complex with inhibitor gsk560 |
|
163
|
560
|
2yniA |
Hiv-1 reverse transcriptase in complex with inhibitor gsk952 |
|
104
|
427
|
2yknB |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with a difluoromethylbenzoxazole (dfmb) pyrimidine thioether derivative, a non-nucleoside rt inhibitor (nnrti) |
|
158
|
560
|
2ynfA |
Hiv-1 reverse transcriptase y188l mutant in complex with inhibitor gsk560 |
|
90
|
366
|
2xurA |
The g157c mutation in the escherichia coli sliding clamp specifically affects initiation of replication |
|
53
|
174
|
2xy8A |
Paramagnetic-based nmr structure of the complex between the n- terminal epsilon domain and the theta domain of the dna polymerase iii |
|
16
|
99
|
2xyfA |
Hiv-1 inhibitors with a tertiary-alcohol-containing transition-state mimic and various p2 and p1 prime substituents |
|
28
|
75
|
2xv6A |
Crystal structure of the hiv-1 capsid protein c-terminal domain (146- 220) in complex with a camelid vhh. |
|
25
|
73
|
2xxmA |
Crystal structure of the hiv-1 capsid protein c-terminal domain in complex with a camelid vhh and the cai peptide. |
|
19
|
61
|
2xy8B |
Paramagnetic-based nmr structure of the complex between the n- terminal epsilon domain and the theta domain of the dna polymerase iii |
|
16
|
99
|
2xyeA |
Hiv-1 inhibitors with a tertiary-alcohol-containing transition-state mimic and various p2 and p1 prime substituents |
|
47
|
136
|
2xdeA |
Crystal structure of the complex of pf-3450074 with an engineered hiv capsid n terminal domain |
|
62
|
188
|
2x6sA |
Human foamy virus integrase - catalytic core. magnesium-bound structure. |
|
55
|
189
|
2x74A |
Human foamy virus integrase - catalytic core. |
|
0
|
9
|
2x4uC |
Crystal structure of mhc class i hla-a2.1 bound to hiv-1 peptide rt468-476 |
|
50
|
146
|
2x2dD |
Acetyl-cypa:hiv-1 n-term capsid domain complex |
|
53
|
187
|
2x78A |
Human foamy virus integrase - catalytic core. |
|
60
|
188
|
2x6nA |
Human foamy virus integrase - catalytic core. manganese-bound structure. |
|
111
|
427
|
2wonB |
Crystal structure of uk-453061 bound to hiv-1 reverse transcriptase (wild-type). |
|
151
|
557
|
2womA |
Crystal structure of uk-453061 bound to hiv-1 reverse transcriptase (k103n). |
|
109
|
427
|
2womB |
Crystal structure of uk-453061 bound to hiv-1 reverse transcriptase (k103n). |
|
151
|
557
|
2wonA |
Crystal structure of uk-453061 bound to hiv-1 reverse transcriptase (wild-type). |
|
16
|
99
|
2wkzA |
Hiv-1 protease inhibitors containing a tertiary alcohol in the transition-state mimic with improved cell-based antiviral activity |
